SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: dale w ruckle who wrote (627)7/6/1998 7:24:00 PM
From: MGV  Read Replies (1) | Respond to of 1754
 
You are right. Technically, according to option valuation theory, its never optimal to exercise a call on a non-dividend paying stock before expiry. Based on that, I don't think it will be called away before expiry Dale but, the way VISX is going, its getting more unlikely that the call price will decline to a point where I could buy back the option at a profit to avoid losing the shares.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News